Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Mazdutide for Sale > Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - large image1
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image1
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image2
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image3
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image4
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image5
Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping buy - image6

Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping

TDS 4 Inquiries

Unit Price:

$110-120/UNIT FOB

Get Latest Price
CAS No.:

2259884-03-0

Grade:

Pharmaceutical Grade

Content:

99%

Port:

GuangZhou

Brand:

EnShi

Packaging:

5mg*10vials

Price valid (until):

2028-01-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

       Name :Leona

    Whatsapp/wechat:+852 96816401

    Email:sjzes4@enshikj.com

    What is Mazdutide ?                                                   

    Mazdutide (development codes: IBI362, LY3305677; also known as OXM-3) is a novel, long-acting, once-weekly synthetic dual agonist of the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR), structurally derived from oxyntomodulin (OXM), an endogenous gut hormone with inherent dual GLP-1R/GCGR activity.  

    As of 2026, mazdutide has obtained official marketing approval from the National Medical Products Administration (NMPA) of China for two core therapeutic indications:

    • Chronic weight management in adults with overweight or obesity, as an adjunct to a reduced-calorie diet and increased physical activity;
    • Glycemic control in adults with type 2 diabetes mellitus (T2DM), including both monotherapy and combination therapy with oral antidiabetic agents.
    This approval marks mazdutide as one of the first domestically developed dual-target metabolic disease therapies to reach the Chinese market, with global clinical development ongoing to support regulatory submissions in the United States, Europe, and other international regions.
    • Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 1
    • Mechanism of Action:                                                

      The superior therapeutic efficacy of mazdutide stems from its synergistic, balanced activation of two distinct G protein-coupled receptors (GPCRs) that play central, non-redundant roles in whole-body metabolic homeostasis: the GLP-1 receptor and glucagon receptor. This dual-target mechanism distinguishes mazdutide from single-target GLP-1 receptor agonists (GLP-1RAs), the current standard of care for obesity and T2DM.

    • Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 2

      Safety and Tolerability Profile:                                  

      Across all completed clinical trials, mazdutide has exhibited a favorable, well-characterized, and predictable safety and tolerability profile, consistent with the known safety profile of the GLP-1RA drug class, with no new unexpected safety signals identified to date.

    • Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 3

    Ongoing Research:                                                   

    Beyond its approved indications for obesity and T2DM, mazdutide's dual GLP-1R/GCGR mechanism supports broad therapeutic potential in a range of metabolic and non-metabolic diseases, with active preclinical and clinical research exploring these expanded indications.

    1.Non-Alcoholic Steatohepatitis (NASH)

    2.Cardiovascular Outcomes

    3.Diabetes-Associated Cognitive Dysfunction

    4.Polycystic Ovary Syndrome (PCOS)

    Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 4

    • Product Specification:                                                

    • Product Name Mazdutide
      CAS 2259884-03-0
      Synonyms IBI362, LY3305677, OXM-3
      Purity >99.0%
      Molecular Weight 4563.06 Da
      Molecular Formula C₂₁₀H₃₂₂N₄₆O₆₇
      Sequence Ac‑Aib‑EGTFTSDYS‑KLDLLRRAQD‑FIEWLIKKGRS‑NH₂ (acylated peptide)
      Storage Stability ≤‑20 °C for 24 months
    • Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 5

    Company Profile:                                                      

    EnShi Technology Co., Ltd is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. With years of experience in the pharmaceutical chemical and biosynthetic industries.It provides compliant, stable and cost-effective core raw materials as well as one-stop CDMO/CMO solutions for global pharmaceutical enterprises and innovative drug R&D institutions.

    Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 6 Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 7 Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 8

    Packing:                                                                     

    Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 9

    Shipping:                                                                   

    Shop Mazdutide CAS 2259884-03-0 99% High Purity Peptide API Lyophilized Powder Global Special Line Shipping-Detailed Image 10

    FAQ:                                                                           

    1. How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you

    2. What's the lead time and shipping ways?
    We will delivery to the package by USPS, FEDEX, DHL paket and YANWEN express to you after receive your payment, it would take around 5-15 days to your address.

    3. How do i keep the peptides when i receive it ?
    Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

    4. What's the payment methods ?
    We could accept pay through paypal,bank transfer, XTransfer and bitcoin.

    Certificates

    Basic Info
    Product Name:

    Mazdutide

    Other Name:

    Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)

    CAS No.:

    2259884-03-0

    Molecular Weight:

    0

    EC Number:

    884-103-0

    Color/Form:

    White to off-white

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2025

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    Nigeria

    Mazdutide 10mg

    20 PCS Mar 7, 2026
    United States

    Mazdutide

    30 MG Jul 15, 2024
    United Kingdom

    Mazdutide

    1 KG Feb 10, 2026
    United States

    Mazddultide cas

    2 MT Nov 14, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.